财中社2月9日电爱康医疗(01789)发布公告,预计截至2024年12月31日止年度未经审核的归母净利润较截至2023年12月31日止年度的1.82亿元相比增长50%。
归母净利润增加主要由于:在国家带量采购政策推动下,进一步加速出口替代,国家带量采购带动集团产品的手术量需求持续增长及集团产品收入增加;通过集团有效成本控制手段,经营成本及行政开支相对稳定。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.